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Collagen XVII, a type II transmembrane protein and
epithelial adhesion molecule, can be proteolytically
shed from the cell surface to generate a soluble colla-
gen. Here we investigated the release of the ecto-
domain and identi®ed the enzymes involved. After
surface biotinylation of keratinocytes, the ectodomain
was detectable in the medium within minutes and
remained stable for >48 h. Shedding was enhanced by
phorbol esters and inhibited by metalloprotease inhi-
bitors, including hydroxamates and TIMP-3, but not
by inhibitors of other protease classes or by TIMP-2.
This pro®le implicated MMPs or ADAMs as candidate
sheddases. MMP-2, MMP-9 and MT1-MMP were
excluded, but TACE, ADAM-10 and ADAM-9 were
shown to be expressed in keratinocytes and to be
actively involved. Transfection with cDNAs for the
three ADAMs resulted in increased shedding and, vice
versa, in TACE-de®cient cells shedding was sig-
ni®cantly reduced, indicating that transmembrane
collagen XVII represents a novel class of substrates
for ADAMs. Functionally, release of the ectodomain
of collagen XVII from the cell surface was associated




The family of type II transmembrane collagens includes
collagens XIII, XVII and ectodysplasin A as adhesion
molecules and/or ligand binding receptors on epithelial
cell surfaces, and the types I and II macrophage scavenger
receptors, and the MARCO protein, which have been
proposed to function as receptors in host defense (Krieger
and Herz, 1994; SchaÈcke et al., 1998; Snellman et al.,
2000; Elomaa et al., 2001; Sankala et al., 2002). Collagens
XIII, XVII and ectodysplasin A are epidermal proteins
with a collagenous ectodomain that colocalizes with
integrins on basal keratinocyte surfaces. Collagen XIII
and ectodysplasin A are associated with a3b1 integrin and
the actin cytoskeleton in focal contacts (Ezer et al., 1999;
Snellman et al., 2000), and collagen XVII with a6b4
integrin and the keratin intermediate ®laments in hemi-
desmosomes (Borradori and Sonnenberg, 1999). These
features imply speci®c functions in epithelial cell adhesion
and suggest putative ligand interactions between the
transmembrane collagens and the integrins in the basal
keratinocytes.
Collagen XVII is a component of hemidesmosomes
which mediate adhesion of keratinocytes and certain other
epithelial cells to the underlying basement membrane. Its
intracellular domain interacts with the b4-integrin subunit
and is essential for the incorporation of the molecule into
the hemidesmosome, and the extracellular juxtamem-
branous NC16A domain binds to the a6-integrin subunit
(Borradori and Sonnenberg, 1999). Each collagen XVII
molecule is a trimer of three 180 kDa a1(XVII) chains,
with a globular intracellular N-terminal domain of 466
amino acids, a short transmembrane domain of 23 amino
acids and an extracellular C-terminal domain of 1008
amino acids in length. The ectodomain consists of 15
collagenous subdomains characterized by typical col-
lagenous -G-X-Y- repeat sequences, intervened by 16
short noncollagenous sequences. The overall structure is
¯exible, rod-like and triple helical, with a signi®cant
thermal stability (SchaÈcke et al., 1998; Tasanen et al.,
2000a; Areida et al., 2001). The critical role of collagen
XVII in maintaining epithelial adhesion is best demon-
strated by human skin diseases. Mutations in the collagen
XVII gene, COL17A, lead to junctional epidermolysis
bullosa, a blistering disorder with epidermal detachment
from the basement membrane as a consequence of minor
friction (McGrath et al., 1995; Tasanen et al., 2000b). In
autoimmune diseases of the pemphigoid group, autoanti-
bodies target both full-length collagen XVII and the shed
ectodomain and lead to diminished epidermal adhesion
and skin blistering (Schumann et al., 2000).
Collagen XVII was the ®rst collagen shown to be
consitutively shed from the cell surface, yielding a soluble
basement membrane collagen (Hirako et al., 1998;
SchaÈcke et al., 1998). Subsequently, shedding of collagen
XIII (Snellman et al., 2000) and ectodysplasin A (Chen
et al., 2001; Elomaa et al., 2001) was described. Although
furin has been predicted to be involved in the shedding
cascade (SchaÈcke et al., 1998; Snellman et al., 2000; Chen
et al., 2001), it has remained unclear whether it cleaves
directly the ectodomains of all of these proteins or is
perhaps involved in the activation of other, physiological,
sheddases. In the present study we demonstrate that three
members of the ADAM family act as physiological
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sheddases of collagen XVII, and that furin is likely to be
involved in the activation of these enzymes.
Results
Domain-speci®c antibodies de®ne the shed
ectodomain of collagen XVII
For characterization of the two forms of collagen XVII,
two novel antibodies, Endo-2, recognizing the intracellular
domain, and Ecto-5, against the distal-most 50 amino
acids of the extracellular C-terminus of collagen XVII
(Figure 1), were produced. The antibody NC16A to the
juxtamembranous extracellular domain (Schumann et al.,
2000) was also used. Since both NC16A and Ecto-5
recognized full-length collagen XVII and the soluble
ectodomain, the authentic shedding product clearly spans
almost the entire extracellular domain of collagen XVII.
Correspondingly, Endo-2 recognized only the full-length
molecule (Figure 1). Thus, the sheddase cleavage site is
predicted to localize close to the cell membrane within the
extracellular NC16A domain.
Release of collagen XVII ectodomain from
the cell surface
Human keratinocytes were surface biotinylated, washed
carefully, and the release of the labeled ectodomain into
fresh medium was followed over time. The biotinylated
ectodomain could be immunoprecipitated from the
medium after 9 min, and after 2 h signi®cant amounts
were recovered (Figure 2). Full-length collagen XVII was
progressively cleaved, and after 48 h no intact molecules
were found in the cell extracts. Interestingly, the intact
ectodomain was still recovered from the medium after
72±96 h, indicating a high stability of the soluble form of
collagen XVII. The ectodomain was puri®ed from the
medium by immunoaf®nity chromatography and subjected
to N-terminal sequencing. However, despite repeated trials
with suf®cient amounts of protein the sequence remained
elusive, because the newly generated N-terminus was
blocked.
Modulation of shedding
For characterization of the enzymes involved in the
shedding of collagen XVII, keratinocytes were cultured
in the presence of protease inhibitors (Table I). Release of
the ectodomain was completely inhibited by phenanthro-
line and by the MMP- and sheddase-targeting hydrox-
amate derivates BB 3103, BB 3241, and IC-3. About 50%
inhibition was observed with 25 mM hydroxamate FN-439
and with 500 nM TIMP-3, ~10% with 500 nM TIMP-1,
Fig. 1. Schematic representation of collagen XVII and the epitope
regions recognized by antibodies. The full-length collagen XVII is a
type II integral transmembrane protein, which is cleaved to yield a
soluble ectodomain. White bars, collagenous sequences; light gray bars,
non-collagenous sequences; black line, the cell plasma membrane. Dark
gray bars, epitope regions of the domain-speci®c antibodies. Endo-2 re-
cognizes the intracellular domain, NC-16A the juxtamembranous extra-
cellular NC16a-domain, and Ecto-1 (SchaÈcke et al., 1998) and Ecto-5
the distal C-terminus of the molecule. The lower panel shows immuno-
blots of keratinocyte cell layer (C) and media (M) with the above anti-
bodies. Ecto-1, Ecto-5, and NC16A recognized both the 180 kDa full-
length collagen XVII and the 120 kDa soluble ectodomain. In contrast,
Endo-2 recognized only full-length collagen XVII.
Fig. 2. Shedding of collagen XVII ectodomain. (A) Time-chase experi-
ments with normal human keratinocytes. The cells were surface bio-
tinylated, chased with biotin-free medium and cultured for 96 h.
Aliquots of culture medium and cell extract were immunoprecipitated
with antibody Ecto-1 or Endo-2 and analyzed by protein blotting with
streptavidin±alkaline phosphatase. The lower panel shows the densito-
metric analysis of the signals. Note that the intact ectodomain was
stable in the medium for at least 72 h. (B) Shedding was stimulated by
phorbol esters and IL-1b. Keratinocytes were cultured for 24 h in the
presence of 100 nM PMA or IL-1b (5 ng/ml). Aliquots were drawn at
regular intervals and analyzed by immunoblotting with Endo-2 and
NC16A antibodies. The signals were analyzed densitometrically with
TotalLab1D (Phoretics) software.
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but none with the aspartate protease inhibitor pepstatin A,
the cystein peptidase inhibitor E-64, or the serine protease
inhibitors AEBSF, aprotinin, or benzamidine. In addition,
no effect was seen with TIMP-2 or with CTTHWGFTLC,
a speci®c cyclic peptide inhibitor of MMP-2 and MMP-9.
Potential stimulators of collagen XVII shedding were
also added to keratinocytes. No effect on shedding of
collagen XVII was observed with 5 ng/ml TNF-a or
5±10 ng/ml TGF-b2 (not shown). In contrast, 6 h after
addition of 5 ng/ml IL-1b, increased ectodomain release,
with a concomitant decrease of full-length collagen XVII,
was seen (Figure 2B). Addition of 100 nM phorbol 12-
myristate 13-acetate (PMA) induced shedding after 24 h
(Figure 2B). Both agents are well-known stimulators of
shedding and inducers of several ADAMs (Hooper et al.,
1997; Flannery et al., 1999).
Exclusion of furin, BMP-1, MMP-2, MMP-9 and
MT1-MMP as collagen XVII sheddases
The above inhibitor and stimulator pro®les indicated that
the protease(s) involved in shedding of collagen XVII
belong(s) to the metalloproteinases, e.g. MMPs or
sheddases of the ADAM family. Enzymes associated
with keratinocyte surfaces, such as furin, BMP-1, MMP-2,
MMP-9 and MT1-MMP (MMP-14), were tested for their
capacity to cleave authentic puri®ed collagen XVII
(Figure 3A). No cleavage was observed with recombinant
furin or BMP-1. All three MMPs cleaved collagen XVII
into a 140 kDa fragment in vitro. Immunoblotting with the
antibody Endo-2 demonstrated that in addition to the
ectodomain, the fragment contained part of the endodo-
main and, therefore, this cleavage was not physiologically
relevant (not shown). The observations were corroborated
by studies on MT1-MMP- and MMP-2-de®cient cells.
After 24 h in culture, the shed ectodomain and full-
length collagen XVII were analyzed by immunoblotting
(Figure 3B). MMP-2-de®cient human gastric carcinoma
cells, which had only low MT1-MMP expression, and
primary MT1-MMP-de®cient murine keratinocytes
generated the ectodomain as ef®ciently as control
keratinocytes (Figure 3B), indicating that these MMPs
were not involved in the shedding of collagen XVII.
Support for the involvement of TACE, instead of the
above MMPs, was obtained from comparisons of the
inhibitor pro®les of metalloproteases and collagen XVII
shedding. Recombinant human MMP-2, MMP-9 and
TACE were used to cleave ¯uorescein-coupled gelatin or
internally quenched ¯uorescent oligopeptides. Inhibitors
of collagen XVII shedding, i.e. IC-3, BB 3241 and
BB 3103 strongly inhibited MMP-2, MMP-9 and TACE,
whereas the hydroxamate FN-439, a weak inhibitor of
shedding, had only little effect on the activity of the MMPs
and TACE (Table II). In contrast, the gelatin inhibitor,
which did not inhibit collagen XVII shedding, strongly
inhibited MMP-2 and MMP-9, but not TACE.
The role of furin in collagen XVII shedding was of
interest, since a furin-speci®c chloromethyl ketone inhib-
itor prevents collagen XVII processing (SchaÈcke et al.,
1998). The fact that recombinant furin did not cleave
puri®ed collagen XVII in vitro (Figure 3A) and was not
sensitive to hydroxamates (Table II) suggested that furin is
indirectly involved in the activation of a convertase. To
verify this, TACE expression was analyzed in keratino-
cytes treated with the furin inhibitor (Figure 4C).
Immunoblots of control cell lysates showed two distinct






1,10-o-phenanthroline 100 91 6 9
Pepstatin A 100 3 6 4
E-64 100 8 6 8
Phosphoramidon 10 4 6 6
AEBSF 1000 5 6 11
Aprotinin 25 11 6 13
Benzamidine 1000 14 6 9
FN-439 20 20 6 7
200 44 6 10
BB 3103 10 87 6 16
BB 3241 10 92 6 9
IC-3 (TAPI) 25 95 6 4
TIMP-1 0.5 11 6 4
TIMP-2 1 1 6 4
TIMP-3 0.15 15 6 4
0.5 51 6 4
Selective gelatinase inhibitora 100 4 6 3
aCyclic synthetic peptide: CTTHWGFTLC.
Shedding in the presence or absence of inhibitors was analyzed by
immunoblotting followed by semiquantitative densitometry of the
signals. The inhibition is expressed as a percentage 6 SD (n = 3) of
controls.
Fig. 3. Furin, BMP-1, MMP-2, MMP-9 and MT1-MMP are not directly
involved in the processing of collagen XVII. (A) Puri®ed native col-
lagen XVII was digested with recombinant human MT1-MMP, MMP-
2, MMP-9, furin and BMP-1. The digests in the absence (±) or in the
presence (+) of 5 mM EDTA were immunoblotted with antibody Ecto-
1. Furin and BMP-1 did not cleave collagen XVII. MMP-2, MMP-9
and MT1-MMP generated a 140 kDa fragment which was distinct
from the authentic 120 kDa fragment in culture medium (Med).
(B) Ectodomain shedding in MMP-2-de®cient gastric carcinoma cells
(left panel) and MT1-MMP-de®cient murine keratinocytes (right
panel). In both cultures the 120 kDa ectodomain was generated simi-
larly to controls. C, cell extract; M, medium. Immunoblotting was with




TACE-positive bands, representing the proform and the
mature form of the enzyme (Figure 4B and C). Addition of
50 mM furin inhibitor to the cultures inhibited the
activation of TACE, as shown by nearly complete absence
of the mature form (Figure 4C). In contrast, addition of
BB 3103 did not block TACE activation, as shown by the
presence of the proform and the mature form in both
controls and hydroxamate-treated samples (Figure 4C).
Importantly, 10 mM 1,10-o-phenanthroline was added to
the extraction buffers, since it was recently shown that an
additional form of TACE lacking the pro- and cytoplas-
matic domains is detected if cell lysates are prepared
without 1,10-o-phenanthroline (Schlondorff et al., 2000).
Expression of ADAMs in human keratinocytes
Based on the above observations, the ADAM family
proteinases were considered as candidate sheddases for
collagen XVII. RT±PCR ampli®cation of human keratino-
cyte mRNA demonstrated that TACE and the related
sheddases ADAM-9 and ADAM-10 were expressed in
these cells (not shown). Immuno¯uorescence staining of
human skin with antibodies to TACE and ADAM-9
produced a positive signal in the lower epidermis in the
vicinity of collagen XVII (Figure 4A), and ADAM-10 was
found within the entire epidermis. Immunoblotting of
keratinocyte lysates (Figure 4B) demonstrated that the
proform and the active form of TACE (Schlondorff et al.,
2000) and ADAM-9 (Roghani et al., 1999), and the active
form of ADAM-10 (Qi et al., 1999) were present in these
cells.
TACE and other ADAMs contribute to shedding of
collagen XVII
To assess the role of TACE in collagen XVII shedding,
HaCaT cells were transiently transfected with full-length
murine TACE cDNA. Since TACE is expressed in many
cell lines, including HaCaT, different cDNA concentra-
tions (0±20 mg) were used. The transfection ef®ciency was
estimated by analysis of TACE protein expression with
immuno¯uorescence staining and determination of the
relative number of transfected cells with a strongly
positive TACE signal within a de®ned culture area. A
transfection ef®ciency of ~20% was obtained with 20 mg
of TACE cDNA (Figure 5A). A dose-dependent increase
in shedding, with a concomitant decrease in full-length
collagen XVII, was observed with increasing cDNA
concentrations. Transfection with 20 mg of TACE cDNA
led to a nearly 2-fold increase of shedding (Figure 5B).
Enhanced shedding in transfected cells was effectively
inhibited with the hydroxamates BB 3103 or BB 3241
(Figure 6).
In parallel, HaCaT cells were transfected with full-
length cDNA for human ADAM-9 and bovine ADAM-10.
The estimated transfection ef®ciencies with 15 mg of
cDNA for ADAM-9 and ADAM-10 were 12 and 10%,
respectively (Figure 5A). Transfection with 15 mg of
ADAM-10 cDNA caused an ~1.5-fold increase, and with
15 mg of ADAM-9 cDNA a 1.75-fold increase in shedding
of the ectodomain (Figure 5B).
The prediction that TACE sheds collagen XVII was
con®rmed with keratinocytes derived from TACE-
de®cient mouse embryos. Compared with age-matched
normal murine keratinocytes, shedding of collagen XVII
was reduced by ~40% in TACE-de®cient cells (Figure 7A).
In another approach, normal and TACE-de®cient murine
®broblasts were transfected with collagen XVII cDNA,
and shedding was analyzed. Similarly to TACE-de®cient
keratinocytes, transfected TACE-de®cient ®broblasts shed
collagen XVII less ef®ciently. Also in this case the
reduction was ~40% (Figure 7B).
Shedding of collagen XVII ectodomain is
associated with altered cell motility
Since the release of collagen XVII ectodomain from the
keratinocyte surface is likely to in¯uence the interaction of
the cell with its environment, we analyzed cell motility
after transfection of HaCaT cells with cDNAs for TACE,
ADAM-9 and -10. For this purpose, in vitro wound closure
assays were performed (Cha et al., 1996). In this assay,
scrape wounds were generated in con¯uent serum-free
HaCaT cultures and, after extensive washing with PBS,
the cells were allowed to migrate into the denuded area for
22 h at 37°C. Cells transfected with an empty vector
migrated into the wound and `re-epithelialized' it to ~50%
in 11 h and fully in ~22 h (Figure 8A). Cells transfected
with one of the ADAMs were less motile, as indicated by a
lower number of cells in the denuded area after 11 h and
22 h (Figure 8A).
The inhibitory activity of collagen XVII shedding on
cell motility was veri®ed with the addition of ~1 nM




MMP-2 MMP-9 TACE Furin
BB 3103 25 0 6 4 1 6 2 0 6 4 101 6 12
BB 3241 25 0.5 6 3 0 6 3 0 6 1 102 6 9
FN-439 25 36 6 3 58 6 3 45 6 7 93 6 3
Gelatinase inhibitora 25 19 6 11 10 6 10 98 6 12 98 6 9
IC-3 (TAPI) 25 0 6 4 0.3 6 1 0 6 1 102 6 9
Furin inhibitorb 100 97 6 4 88 6 3 97 6 8 6 6 4
aCyclic synthetic peptide: CTTHWGFTLC.
bDecanoyl-RVKR-chloromethyl ketone.
The enzymes (5 nM MMP-2; 4 nM MMP-9; 20 nM CAT-DIS-TACE; 10 nM human furin) and inhibitors were preincubated for 30 min at room
temperature and the ¯uorogenic substrate was added as described in Materials and methods. The proteolytic activity is expressed as a percentage
6 SD (n = 3) in relation to controls.
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puri®ed ectodomain to the culture medium after induction
of the scrape wound. Similarly to the experiment described
above, untreated control cells readily migrated into the
scraped area, covering it to >50% in 16 h. In contrast,
keratinocyte migration from the cut edge was decreased
when the puri®ed ectodomain was added to the culture
medium (Figure 8B), suggesting that the shed ectodomain
negatively regulates cell motility.
Discussion
A wide variety of proteins, including cytokines, growth
factors and their receptors, and cell adhesion molecules,
are synthesized as integral type I or type II transmembrane
proteins that can be released by selective proteolysis from
the cell surface (Hooper et al., 1997). The cleavage
generally occurs close to the extracellular face of the
membrane, generating a physiologically active protein.
Release of soluble growth factors and cytokines may
change their biological activities, whereas shedding of
transmembrane receptors may render cells unresponsive to
Fig. 5. Transient transfections of HaCaT cells with cDNAs for TACE,
ADAM-9 and ADAM-10. (A) Immuno¯uorescence staining of trans-
fected cells. Cells transfected with empty vector (control) remained
negative, but ADAM-transfected cells showed strong positive signals.
Scale bar: 100 mm. (B) HaCaT cells were transfected with different
concentrations of cDNA for TACE (upper panel), ADAM-10 (middle
panel) and ADAM-9 (lower panel) and shedding of collagen XVII was
assessed with immunoblotting with a mixture of antibodies Endo-2,
NC16A and Ecto-1. Densitometric analysis of the signals (expressed as
a percentage of the control 6 SD; n = 3) showed a dose-dependent
increase of ectodomain shedding, with a concomitant decrease of
full-length collagen XVII.
Fig. 4. Expression of ADAMs in human keratinocytes. (A) Immuno-
¯uorescence staining of collagen XVII and ADAMs in the skin.
Collagen XVII antibody NC16A produced a linear signal at the base-
ment membrane zone (a). TACE (b) and ADAM-9 (c) immuno-
reactivity was stronger in the lower epidermis, in the neighborhood of
collagen XVII, whereas ADAM-10 immunoreactivity (d) was dis-
tributed throughout the entire epidermis. Scale bar: 250 mm.
(B) Immunoblot of keratinocyte extracts with antibodies to the ecto-
domains of TACE and ADAM-9, and the endodomain of ADAM-10.
TACE and ADAM-9 antibodies recognized two distinct protein bands
of ~120 and 85 kDa, and 110 and 79 kDa, respectively, representing the
proform and the active form of the enzymes. ADAM-10 antibody recog-
nized one band of ~60 kDa, corresponding to the active form.
(C) Activation of TACE in keratinocytes was inhibited by a furin
inhibitor, but not by hydroxamates. Keratinocytes were cultured for 24 h
in serum-free medium with or without 50 mM furin inhibitor decanoyl-
RVKR-chloromethyl ketone or 25 mM hydroxamate BB 3103.
Keratinocyte lysates were immunoblotted with TACE antibodies. The
furin inhibitor, but not BB 3103, prevented the conversion of pro-TACE
to active TACE. Molecular weight markers are shown on the left.
C.-W.Franzke et al.
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particular ligands, and the resulting soluble molecules may
act to modulate the activity of their ligands (Black and
White, 1998). Thus, the process of ectodomain shedding
can in¯uence the interaction of cells with their environ-
ment in multiple ways.
Many of the recently characterized sheddases are
metalloproteinases (Hooper et al., 1997). They are local-
ized at the cell surface, or are themselves integral
membrane proteins which after activation can act close
to the cell membrane in the extracellular space. The
prototype sheddase TACE is a member of the ADAM
family and was designated as ADAM-17. The substrate
spectrum of TACE is broad, including TNF-a, L-selectin,
IL-6 receptor and the p75 TNF receptor (Moss et al., 1997;
Merlos-Suarez et al., 1998; Peschon et al., 1998). Both
TACE and ADAM-10 may also participate in the
processing of amyloid precursor protein (Buxbaum et al.,
Fig. 6. Hydroxamates inhibit increased collagen XVII shedding in
TACE-transfected cells. The cells were electroporated with empty
vector (control), or with 10 or 20 mg of TACE cDNA. After 24 h the
cells were washed, 10 mM BB 3103 or BB 3241 added, and after 6 h
the ectodomain in the medium detected with immunoblotting using
antibodies NC16A and Ecto-1. Both hydroxamates strongly inhibited
shedding in this system.
Fig. 7. Decreased collagen XVII shedding in TACE-de®cient cells.
(A) Murine keratinocytes from wild-type (WT) and TACE ±/± mice
were analyzed for collagen XVII shedding in vitro. Cells (C) and
media (M) were sampled after 6 h and immunoblotted with a mixture
of antibodies MO-NC16A and Endo-2 (left panel). The relative inten-
sity of the signals of three individual experiments is expressed as a per-
centage 6 SD (right panel). (B) Wild-type (WT) and TACE ±/±
®broblasts were transfected with human collagen XVII cDNA. After
2 days the cells were analyzed for collagen XVII shedding. Cells (C)
and media (M) were sampled after 6 h and immunoblotted with a mix-
ture of antibodies MO-NC16A and Endo-2 (left panel). The relative
intensity of the signals of two different experiments is expressed as a
percentage 6 SD (right panel).
Fig. 8. Increased collagen XVII shedding correlates with decreased cell
motility. In wound closure assays cells migrate from the edges of a
`scrape wound' in the monolayer (interrupted lines) to cover the
denuded space (between the lines). Scrape wounds were made in
serum-free cultures, and after washing the cells were allowed to re-
epithelialize for 22 h at 37°C. Micrographs of non-®xed cell layers at
0, 11, 16 or 22 h after wounding are shown. Scale bars: 200 mm.
(A) Transfection of HaCaT cells with ADAM cDNA negatively regu-
lated cell motility. Transfections were with 15 mg of empty vector
(control), 15 mg of TACE, 15 mg of ADAM-10, or 15 mg of ADAM-9
cDNA. (B) Addition of puri®ed collagen XVII ectodomain to normal
human keratinocytes inhibited cell motility. After wounding, 1 nM col-
lagen XVII ectodomain was added to the culture, and the cells were
permitted to migrate into the denuded space for 16 h. Ectodomain-trea-
ted cells did not cover the denuded area as ef®ciently as control cells.
ADAMs shed collagen XVII
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1998; Amour et al., 2000). Another member of the family,
ADAM-9, mediates the shedding of heparin-binding
epidermal growth factor-like growth factor (Izumi et al.,
1998). Kuzbanian, the Drosophila homolog of mammalian
ADAM-10, releases the Notch ligand Delta from cells (Qi
et al., 1999). Thus, the ADAMs constitute a family of
sheddases that regulate plasma membrane composition
and release soluble signaling molecules and ligand binding
receptors from cells. In the present study, we expand the
substrate spectrum of ADAM sheddases by showing that
collagen XVII, a representative of the family of trans-
membrane collagens, is a substrate for TACE, ADAM-9
and ADAM-10.
Genetic evidence proves collagen XVII is an essential
keratinocyte adhesion molecule. Mutations in the
COL17A1 gene lead to severe epidermal dysadhesion
and skin blistering in humans (McGrath et al., 1995). The
shed ectodomain forms a soluble collagen which remains
stable for days in keratinocyte media in vitro and which
can be isolated from the epidermis and amniotic ¯uid
in vivo, suggesting that it functions as a ligand-binding
matrix molecule (Zone et al., 1990; Schumann et al.,
2000).
The sheddase cleavage site within the ectodomain of
collagen XVII remains elusive. Epitope mapping placed
the putative site within the 76 amino acid NC16A domain
adjacent to the cell membrane, but determination of the
cleaved peptide bond was impeded by the fact that the
newly generated N-terminus was blocked and not amen-
able to amino acid sequencing. Since shedding of collagen
XVII in keratinocytes was completely inhibited by the
synthetic furin inhibitor decanoyl-RVKR-chloromethyl
ketone, and since the NC16A domain contains a conserved
furin cleavage motif, RIRR, we ®rst assumed that furin
releases the ectodomain from the cell surface (SchaÈcke
et al., 1998). However, recombinant furin did not cleave
immunopuri®ed full-length collagen XVII in vitro and,
more importantly, shedding was completely blocked by
hydroxamate inhibitors, such as BB 3103, BB 3241 or
IC-3, which do not inhibit furin.
Based on the above data and the fact that the furin
inhibitor completely blocked the activation of TACE
proform, it is likely that furin activates ADAMs that shed
collagen XVII. TACE, ADAM-10 and -9 are expressed as
an inactive proform in keratinocytes. They all contain a
conserved sequence in the prodomain which is comparable
to the cysteine switch sequence of MMPs (Nagase and
Wossner, 1999). In addition, in the boundary between the
prodomain and the metalloproteinase domain there is a
four basic amino acid consensus motif for furin cleavage
(RRRR in ADAM-9, RKKR in ADAM-10 and RVKR in
ADAM-17), suggesting that the mechanism of activation
of these ADAMs includes a cysteine switch and
proteolytic removal of the prodomain by furin (Merlos-
Suarez et al., 1998; Lammich et al., 1999; Roghani et al.,
1999; Schlondorff et al., 2000).
Our results demonstrate that all three ADAMs can shed
collagen XVII in keratinocytes, since transient transfec-
tions with TACE, ADAM-9 and ADAM-10 lead to
increased shedding of the ectodomain, and since TACE-
de®cient keratinocytes exhibited a remaining shedding
activity of ~60%. Three observations argue that TACE
may be the major sheddase. First, shedding was sensitive
to TIMP-3, but not to TIMP-1 or TIMP-2. TIMP-3 is
known to inhibit shedding of proTNF-a and the adhesion
molecules L-selectin, syndecan-1 and -4 (Borland et al.,
1999; Fitzgerald et al., 2000). Secondly, expression of
TIMP-3 in keratinocytes is downregulated by IL1-b
(Airola et al., 1998), a stimulator of collagen XVII
shedding. Thirdly, TIMP-3, but not TIMP-1 and TIMP-2,
inhibited recombinant TACE in vitro (Amour et al., 1998).
In contrast, the proteolytic activity of ADAM-10 and
ADAM-9 is inhibited also by TIMP-1 (Dethlefsen et al.,
1998; Amour et al., 2000). Compared with TIMP-3, an
equimolar concentration of TIMP-1 inhibited collagen
XVII shedding by only ~10%. The synergistic action of the
three ADAMs has also been observed in another system:
all three enzymes have been postulated to represent
potential a-secretases that can cleave amyloid precursor
protein or corresponding peptides in vitro (Buxbaum et al.,
1998; Schlondorff and Blobel, 1999; Fahrenholz et al.,
2000).
The biological context of collagen XVII shedding is
predicted to involve keratinocyte adhesion, differentiation
and migration. These processes are very complex and
involve a number of receptors and ligands depending on
the spatial and temporal biological context (Aumailley and
Gayraud, 1998; Nguyen et al., 2000), but a scenario could
be visualized in which shedding of collagen XVII
ectodomain loosens or releases the cell from some of its
present binding partners and allows it to embark on other
functions as required. We have previously shown that
recombinant Col15 domain, the largest collagenous
domain of collagen XVII, promotes epithelial cell adhe-
sion in a b1 integrin-dependent manner, and that denatured
Col15 binds cells more ef®ciently than its native counter-
part (Tasanen et al., 2000a). We concluded that the shed
ectodomain, which contains Col15, may exert this func-
tion, and that shedding may generate new cell binding
sites. The hypothesis is supported by the in vitro re-
epithelialization assays of the present study, which showed
that increased shedding of collagen XVII induced by
transient transfections with ADAM cDNA, or simulation
of shedding through addition of exogenous ectodomain,
was associated with decreased keratinocyte motility.
Basal keratinocytes in the skin express a2, a3, a5 and
aV integrin subunits in association with the b1 subunit and
utilize them for cell migration on collagen and laminin e.g.
during wound healing. a2b1 is used for adhesion to
collagen, but this integrin does not recognize the
ectodomain of collagen XVII (Nykvist et al., 2001).
a6b4 and a3b1 are laminin 5-receptors and regulate
anchorage and motility of epithelial cells (Ryan et al.,
1999). O'Toole et al. (1997) observed an inhibitory effect
of laminin 5 on keratinocyte motility and showed that this
could be reversed by blocking the a3 integrin receptor.
Ryan et al. (1999) demonstrated that basal keratinocytes
can utilize integrin a3b1 to interact with a hitherto
unknown alternative ligand. Therefore, it is feasible to
postulate that the shed ectodomain of collagen XVII is an
alternative ligand that can bind to a3b1 integrin and block
it for other, migration-enhancing ligands.
Taken together, it is likely that an interplay between
stimulatory and inhibitory regulators determines collagen
XVII shedding activity in a given cell at a given time.
Future studies must show how the enzyme activities,
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enzyme±substrate interactions and ligand binding
activities are modulated. Finally, the possibility cannot
be excluded that hitherto unknown constitutive sheddases,
like the as yet uncharacterized shedding activities of
TRANCE/OPGL (Schlondorff et al., 2001), also partici-
pate in the regulation of keratinocyte adhesion and
migration.
Materials and methods
Production of bacterial fusion proteins and domain-speci®c
collagen XVII antibodies
For production of domain-speci®c antibodies to collagen XVII, bacterial
fusion proteins were generated as described (Tasanen et al., 2000a,b). The
fusion protein GST±Ecto-5 spanned amino acids 1447±1497 and
GST±Endo-2 spanned amino acids 367±466 (Figure 1). The correspond-
ing primers for Ecto-5 were: sense primer 5¢-GCGCGGATCCGG-
CACTCCAGGACCCAAAGGT-3¢ and antisense primer 5¢-GCG-
CGAATTCTCACGGCTTGACAGCAATATC-3¢; and for Endo-2,
sense primer 5¢-CGGGATCCAGCGGGAAGGTCTTTACAGCC-3¢ and
antisense primer 5¢-GGAATTCACTTCCACCAGCTGCAGCA-3¢. In
parallel, a fusion protein corresponding to the NC16A domain of murine
collagen XVII, MO-NC16A, spanning amino acids 499±573, was
produced. The corresponding cDNA was ampli®ed by RT±PCR from
murine keratinocyte mRNA with sense primer 5¢-GCGCGGATCCGAG-
GAGGTAAGAAAGCTGAAG-3¢ and antisense primer 5¢-GCGCGAA-
TTCATCTGAGATTCCCGTTCTCCTG-3¢. Rabbit antibodies to the
fusion proteins were produced by standard procedures (Eurogentec,
OugreÂe, Belgium).
Cell cultures
Normal human keratinocytes were cultured in serum-free keratinocyte
growth medium (KGM; Life Technologies, Grand Island, NY) as
described (SchaÈcke et al., 1998). The human keratinocyte cell line
HaCaT was a generous gift of Dr N.Fusening (German Cancer Research
Center, Heidelberg, Germany). Prior to experiments, cells were grown in
the presence of 50 mg/ml L-ascorbate for 48 h in order to allow for full
prolyl- and lysyl hydroxylation of newly synthesized collagens.
TACE-de®cient murine keratinocytes were isolated from taceDZn/DZn
mouse embryos (Dotto, 1999). The mice were homozygous for a targeted
mutation in the metalloproteinase domain of TACE which leads to
expression of inactive TACE (Peschon et al., 1998). MT1-MMP-de®cient
murine keratinocytes were isolated from the skin of MT1-MMP knockout
mice (Zhou et al., 2000) and cultured as described above for human
keratinocytes. The MMP-2-de®cient human gastric carcinoma cell line
(MKN 45), which had only low MT1-MMP expression, was obtained
from the Japanese Cancer Resource Bank (JCRB). Murine ®brobasts and
the MKN 45 cells were maintained in DMEM supplemented with
L-glutamine, 10% fetal calf serum (FCS) and penicillin/streptomycin
(Life Technologies GmbH, Karlsruhe, Germany).
Surface biotinylation and time chase experiments
For time chase analysis of the release of the ectodomain, semicon¯uent
keratinocytes were cultured with 50 mg/ml for 48 h, washed extensively
and surface biotinylated with d-biotinoyl-e-aminocaproic acid
N-hydroxysuccinimide ester according to the manufacturer's recom-
mendations (Roche Biochemicals, Mannheim, Germany). After washing
with phosphate-buffered saline (PBS) ®ve times, the cells were cultured
in fresh medium supplemented with ascorbate, and aliquots were
collected at regular intervals over 96 h. Culture medium and cell extract
were immunoprecipitated with the antibodies Ecto-1 and Endo-2,
respectively. The precipitates were immunoblotted with a streptavidin-
coupled alkaline phosphatase (Sigma, Germany) to detect biotinylated
collagen XVII. The software TotalLab1D V1.00 from Phoetix (Biostep
GmbH, Jahnsdorf, Germany) was used for semiquantitative analysis of
the signals.
Protein extractions
For protein extractions, the media and cells were processed separately as
described (SchaÈcke et al., 1998). As a modi®cation, 10 mM 1,10-o-
phenanthroline was added to the extraction buffer. After centrifugation at
13 000 g for 5 min at 4°C the supernatant was used for further analysis.
The medium was collected on ice, proteinase inhibitors were added
immediately and cell debris removed by centrifugation. The supernatant
was precipitated with ethanol and resuspended in a buffer containing
50 mM Tris±HCl, 65 mM NaCl, 5 mM EDTA, 1 mM Pefabloc pH 7.4.
Total protein content was determined with a micro-Lowry assay kit
(Bio-Rad), and samples containing 50 mg of protein were analyzed by
immunoblotting.
Immunoblotting and immunoprecipitation of collagen XVII
SDS±PAGE and immunoblotting with collagen XVII antibodies Endo-2,
Ecto-5, murine or human NC16A (Schumann et al., 2000), or Ecto-1
(SchaÈcke et al., 1998) were performed using standard techniques.
For immunoprecipitation, cell extracts were precleared with
protein A±Sepharose (Amersham Pharmacia Biotech) for 30 min and
centrifuged at 2000 g for 5 min. The supernatants were incubated with
antibody Endo-2/protein A±Sepharose complexes at 4°C overnight. After
extensive washing, collagen XVII was eluted with 0.1 M glycine pH 2.5
for 5 min and immediately neutralized with 1 M Tris.
Digestion of collagen XVII with recombinant proteases
Immunoprecipitated collagen XVII was digested with recombinant
MMP-14 (MT1-MMP) and pro-MMP-9 (Alexis Deutschland,
GruÈnberg, Germany), recombinant pro-MMP-2, recombinant BMP-1,
and recombinant furin (Calbiochem-Novabiochem, Bad Soden,
Germany). The proforms of MMP-2 and MMP-9 were activated with
1 mM APMA for 1 h at 37°C. Collagen XVII was incubated with 1±5 nM
recombinant enzymes in 50 mM Tris±HCl pH 7.5, 150 mM NaCl, 5 mM
CaCl2, 15 mM ZnCl2 and 0.3% Brij 35 for up to 4 h at 37°C. The reactions
were stopped with 5 mM EDTA and the samples precipitated with
methanol/chloroform for immunoblotting with antibodies Ecto-1 and
Endo-2.
Protease inhibitors
The following protease inhibitors were used: AEBSF [4-(2-aminoethyl)-
benzolsulfonyl¯uoride hydrochloride; Merck, Darmstadt, Germany),
phosphoramidon, 1,10-o-phenolanthroline, aprotinin, benzamidine,
E-64 [L-3-carboxy-2,3-trans-epoxypropionyl-leucylamido(4-guanidino)-
butane], pepstatin A (Sigma), the MMP-inhibitor 4-Abz-Gly-Pro-D-Leu-
D-Ala-NHOH (FN-439; Calbiochem-Novabiochem) and the furin
inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone (Calbiochem-
Novabiochem). The hydroxamate inhibitors BB 3103, BB 3241 were
from British Biotech and IC-3 from Immunex Corp. TIMP-1, -2 and
TIMP-3 were from Chemicon International (Hofheim, Germany) and the
selective gelatinase inhibitor H-Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-
Cys-OH (Koivunen et al., 1999) from Bachem (Heidelberg, Germany).
Collagen XVII shedding assay
Subcon¯uent keratinocytes or HaCaT cells were washed twice with PBS,
and fresh medium containing 50 mg/ml ascorbate and inhibitors or
stimulators was added for 4±6 h. Media were precipitated with methanol/
chloroform and aliquots containing 75 mg of total protein were
immunoblotted with antibody NC16A. Semiquantitative densitometry
of the signals was performed using the computer program TotalLab1D
(Biostep GmbH).
Protease activity assay with ¯uorescent substrates
Pro-MMPs were activated with 1 mM APMA for 60 min at 37°C, and
5 nM MMP-2 and 4 nM MMP-9 in buffer containing 50 mM Tris±HCl,
200 mM NaCl, 5 mM CaCl2, 1 mM ZnCl2, 0.05% Brij 35 pH 7.5, were
incubated with 15 mg/ml ¯uorescein-conjugated gelatin (DQ-gelatin from
pig skin; Molecular Probes), and the release of soluble ¯uorescent
fragments was followed with a spectro¯uorometer with microplate reader
set (FluoroMax-2; Jobin Yvon, Munich, Germany; lex = 485 nm,
lem = 530 nm). The activities of recombinant furin and CAT-DIS
TACE were determined with internally quenched ¯uorescent substrates in
assay buffer. For furin, 5 mM Abz-RVKRGLA-m-nitro-YD-OH
(Bachem; lex = 320 nm, lem = 425 nm; Angliker et al., 1995) and for
TACE, 15 mM MCA-PLAQAV-dinitrophenyl-2,3-diaminopropianyl-
RSSSR-NH2 (Sigma; lex = 325 nm, lem = 395 nm) was used.
Immuno¯uorescence staining
Immunofuorescence staining of human skin and keratinocytes was
performed as described (Schumann et al., 2000). As ®rst antibodies,
collagen XVII antibody NC16A, TACE antibodies against the extra-
cellular pro- and metalloproteinase domains (Santa Cruz Biotechnology)
and the intracellular C-terminus (Chemicon International, Hofheim,
Germany), and antibodies to ADAM-10 endodomain (Chemicon) and
ADAM-9 ectodomain (R&D Systems, Wiesbaden, Germany) were used.
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The second antibodies were ¯uorescein isothiocyanate (FITC)-labeled
anti-rabbit immunoglobulins (Sigma).
Transient transfections
One day before transfection with pcDNA3 vectors containing full-length
cDNAs for murine TACE, human ADAM-9 cDNA and bovine
ADAM-10, HaCaT cells were seeded and grown to 70% con¯uence.
The cells were harvested and counted, washed twice with PBS and
resuspended in 1.25% DMSO in KGM. The cDNA constructs were added
to 0.6 3 107 cells and electroporated with Gene Pulser (Bio-Rad) with
0.25 V and 960 mFD capacitance. After electroporation the cells were
transferred into pre-warmed medium, washed after 24 h, and shedding
assays were performed.
TACE-de®cient murine ®brobasts were transfected with pcDNA3
vector encoding the full-length human collagen XVII (kindly provided by
L.Borradori, Geneva). One day before transfection the cells were seeded
at a density of ~25 000 cells/cm2 and grown in DMEM/10% FCS. The
transfection was performed with Effectene. Transfection reagent (Qiagen,
Hilden, Germany) was used following the manufacturer's recommenda-
tions. Cells were used 24±48 h post-transfection to obtain maximum
levels of gene expression.
Migration assays
Scratch assays were performed with normal human keratinocytes or
HaCaT cells in 6-well plates (Cha et al., 1996). The cells were grown to
con¯uence and a 2 mm broad denuded scratch was produced in the culture
with a pipette tip. After washing with PBS to remove all ¯oating cells, the
cells at the cut edge were allowed to migrate into the empty zone for
11±22 h. Photographs of identical locations within each scratch were
taken at different time points. Since the doubling time of keratinocytes
under these conditions was ~30 h, the assay assessed mostly cell motility,
not proliferation (Woodley et al., 1988).
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